How about

Discussion in 'Centocor Ortho Biotech' started by Anonymous, Aug 3, 2014 at 3:38 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Here is an idea. Since everything is a POD here now, though it is proven to actually reduce sales in the end, how about We offer some level of training on teaming to sales. A team member is a complete wacko and likes to take credit for every good thing. Points the finger on anything that is less then perfect. The Docs, Hospitals and offices see it and has lead to minimal access for us all. My point is to simply train these people on teaming before the territories die. It really shouldn't matter if they are JBI by title or not. Just dumping more bodies into a territory without guidance is a very bad idea. Know you may have a clue on why the numbers are off target but the competition is crushing.
     

  2. Anonymous

    Anonymous Guest

    Look up the law case of Celltrion vs Janssen Biotech. Remicade has a generic in 2015. How to pay bills when the cha-ching stops from Remicade. If you aren't worried you should be. After seeing that you should stop looking here and start looking for a job. While you have one.
     
  3. Anonymous

    Anonymous Guest

     
  4. Anonymous

    Anonymous Guest

     
  5. Anonymous

    Anonymous Guest

     
  6. Anonymous

    Anonymous Guest

    JBI Immunology is toast. It is highly unlikely this franchise will survive the first POA 2015. All aboard the oncology train.
     
  7. Anonymous

    Anonymous Guest

    Oh really, Wizard? You obviously are not abreast on the latest Stelara numbers. And why in the world would you want the demise of your counterparts? We ALL work for the same company.